Cetalkonium chloride and choline salicylate are combined in topical preparations used for their antiseptic and analgesic properties. Cetalkonium chloride is a quaternary ammonium compound with antiseptic properties, while choline salicylate is a salicylate derivative that provides pain relief and anti-inflammatory effects. This combination is used primarily in oral care products to manage symptoms associated with mouth and throat conditions.
The combination of cetalkonium chloride and choline salicylate is used for:
| Brand Name | Bongel |
|---|---|
| Type | Oral Gel |
| Weight | 0.01%+8.714% |
| Generic | Cetalkonium Chloride + Choline Salicylate |
| Manufacturer | General Pharmaceuticals Ltd. |
| Available in | English বাংলা |
The mechanisms of action for cetalkonium chloride and choline salicylate are:
The onset of relief from symptoms typically occurs within minutes to an hour after application, depending on the form and severity of the condition. Pain relief and antiseptic effects may be felt shortly after use, but optimal results may take some time with continued use.
When applied topically, cetalkonium chloride and choline salicylate are minimally absorbed into the systemic circulation. Their primary action occurs locally at the site of application within the oral cavity, which helps to reduce the risk of systemic side effects.
Both cetalkonium chloride and choline salicylate are primarily eliminated through local action in the mouth and throat. Any systemic absorption of choline salicylate is metabolized by the liver and excreted in the urine. Cetalkonium chloride is mostly eliminated unchanged in the feces.
The dosage and application frequency of cetalkonium chloride and choline salicylate depend on the specific product formulation:
Administration methods vary based on the product:
Common side effects may include:
Overuse or excessive application of cetalkonium chloride and choline salicylate may lead to toxicity, presenting as:
Precautions include:
Interactions are minimal due to the localized application of cetalkonium chloride and choline salicylate. However, caution should be exercised when using other oral medications or treatments to avoid potential additive effects or interference with absorption.
Use with caution in patients with:
Drug interactions are rare with topical products. However, inform healthcare providers of all current medications to rule out potential interactions, especially if taking other topical treatments or systemic drugs.
Food interactions are generally minimal. It is advised to avoid eating or drinking immediately after applying topical products to ensure the medication remains effective. Consult product-specific instructions for best practices regarding food intake.
The safety of cetalkonium chloride and choline salicylate during pregnancy is not well-established. Use should be limited to essential cases, and pregnant individuals should consult their healthcare provider before use.
Both cetalkonium chloride and choline salicylate are minimally absorbed systemically, but caution is still advised when using during lactation. Consult a healthcare provider to evaluate risks and benefits if breastfeeding.
Acute overdose or excessive use may result in severe local irritation, and possible systemic effects if large quantities are ingested. Seek immediate medical attention if an overdose is suspected, and provide supportive care as needed.
Contraindications include:
Follow the product label directions for proper use. Apply or administer the product as directed, ensuring proper hygiene and avoiding excessive use. Consult a healthcare provider if symptoms persist or if there are any concerns about the product’s effects.
Store cetalkonium chloride and choline salicylate products at room temperature (20-25°C or 68-77°F) in a tightly closed container. Keep away from direct light and moisture, and ensure the product is kept out of reach of children.
The volume of distribution is not typically specified for topical formulations of cetalkonium chloride and choline salicylate, as their primary action occurs locally within the oral cavity with minimal systemic absorption.
The half-life of cetalkonium chloride and choline salicylate is not well-defined for topical applications. The effects are localized, and the salicylate component may have a systemic half-life if absorbed, typically around 2-3 hours.
Clearance for cetalkonium chloride and choline salicylate is primarily through local action and minimal systemic absorption. Any absorbed choline salicylate is metabolized in the liver and excreted in the urine, while cetalkonium chloride is mostly eliminated unchanged in the feces.
See in details version Bongel Oral Gel 0.01%+8.714% also Bongel Oral Gel 0.01%+8.714% in bangla